60 Degrees Pharmaceuticals, Inc.
SXTP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $608 | $254 | $223 | $1,160 |
| % Growth | 139.6% | 13.6% | -80.8% | – |
| Cost of Goods Sold | $385 | $475 | $432 | $851 |
| Gross Profit | $223 | -$221 | -$209 | $310 |
| % Margin | 36.7% | -87.1% | -93.7% | 26.7% |
| R&D Expenses | $4,987 | $692 | $526 | $5,511 |
| G&A Expenses | $5,025 | $4,242 | $1,304 | $1,115 |
| SG&A Expenses | $5,025 | $4,242 | $1,304 | $1,115 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$74 | $0 | -$288 | -$5,193 |
| Operating Expenses | $9,938 | $4,934 | $1,541 | $1,434 |
| Operating Income | -$9,715 | -$5,155 | -$1,750 | -$1,124 |
| % Margin | -1,599% | -2,032.8% | -784.2% | -96.9% |
| Other Income/Exp. Net | $1,760 | $1,341 | -$4,427 | -$3,135 |
| Pre-Tax Income | -$7,955 | -$3,814 | -$6,177 | -$4,259 |
| Tax Expense | $0 | $0 | $1 | $1 |
| Net Income | -$7,947 | -$3,766 | -$6,182 | -$4,252 |
| % Margin | -1,308% | -1,485.1% | -2,769.5% | -366.4% |
| EPS | -18.55 | -0.95 | -1.07 | -0.74 |
| % Growth | -1,852.6% | 11.2% | -44.6% | – |
| EPS Diluted | -18.55 | -0.95 | -1.07 | -0.74 |
| Weighted Avg Shares Out | 455 | 3,960 | 5,782 | 5,782 |
| Weighted Avg Shares Out Dil | 455 | 3,960 | 5,782 | 5,782 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8 | $2,287 | $3,989 | $3,173 |
| Depreciation & Amortization | $64 | $100 | $79 | $72 |
| EBITDA | -$7,884 | -$1,427 | -$2,109 | -$1,015 |
| % Margin | -1,297.6% | -562.6% | -944.9% | -87.5% |